149 related articles for article (PubMed ID: 29743419)
1. Metabolic Syndrome and the Risk of New-Onset Atrial Fibrillation in Middle-Aged East Asian Men.
Kim YG; Choi KJ; Han S; Hwang KW; Kwon CH; Park GM; Won KB; Ann SH; Kim J; Kim SJ; Lee SG; Nam GB; Kim YH
Circ J; 2018 Jun; 82(7):1763-1769. PubMed ID: 29743419
[TBL] [Abstract][Full Text] [Related]
2. Cumulative burden of metabolic syndrome and its components on the risk of atrial fibrillation: a nationwide population-based study.
Ahn HJ; Han KD; Choi EK; Jung JH; Kwon S; Lee SR; Oh S; Lip GYH
Cardiovasc Diabetol; 2021 Jan; 20(1):20. PubMed ID: 33468142
[TBL] [Abstract][Full Text] [Related]
3. Association of metabolic syndrome and chronic kidney disease with atrial fibrillation: A nationwide population-based study in Korea.
Choe WS; Choi EK; Han KD; Lee EJ; Lee SR; Cha MJ; Oh S
Diabetes Res Clin Pract; 2019 Feb; 148():14-22. PubMed ID: 30578822
[TBL] [Abstract][Full Text] [Related]
4. Association Between Change in Metabolic Syndrome Status and Risk of Incident Atrial Fibrillation: A Nationwide Population-Based Study.
Lee SY; Lee SR; Choi EK; Kwon S; Yang S; Park J; Choi YJ; Lee HJ; Moon I; Lee E; Han KD; Cha MJ; Oh S; Lip GYH
J Am Heart Assoc; 2021 Aug; 10(16):e020901. PubMed ID: 34369167
[TBL] [Abstract][Full Text] [Related]
5. Long-term metabolic fate and mortality in obesity without metabolic syndrome.
Käräjämäki AJ; Korkiakoski A; Hukkanen J; Kesäniemi YA; Ukkola O
Ann Med; 2022 Dec; 54(1):1432-1443. PubMed ID: 35594302
[TBL] [Abstract][Full Text] [Related]
6. The Impact of Metabolic Syndrome on the Incidence of Atrial Fibrillation: A Nationwide Longitudinal Cohort Study in South Korea.
Kwon CH; Kim H; Kim SH; Kim BS; Kim HJ; Kim DK; Han SW; Ryu KH; Dong Sung J
J Clin Med; 2019 Jul; 8(8):. PubMed ID: 31344944
[TBL] [Abstract][Full Text] [Related]
7. Metabolic syndrome and risk of development of atrial fibrillation: the Niigata preventive medicine study.
Watanabe H; Tanabe N; Watanabe T; Darbar D; Roden DM; Sasaki S; Aizawa Y
Circulation; 2008 Mar; 117(10):1255-60. PubMed ID: 18285562
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of metabolic syndrome and its individual components with risk of atrial fibrillation in different populations.
Zheng Y; Xie Z; Li J; Chen C; Cai W; Dong Y; Xue R; Liu C
BMC Cardiovasc Disord; 2021 Feb; 21(1):90. PubMed ID: 33588759
[TBL] [Abstract][Full Text] [Related]
9. Metabolic syndrome and risk of recurrence of atrial fibrillation after catheter ablation.
Tang RB; Dong JZ; Liu XP; Long DY; Yu RH; Kalifa J; Ma CS
Circ J; 2009 Mar; 73(3):438-43. PubMed ID: 19179774
[TBL] [Abstract][Full Text] [Related]
10. Body Mass Index Variability and Long-term Risk of New-Onset Atrial Fibrillation in the General Population: A Korean Nationwide Cohort Study.
Lim YM; Yang PS; Jang E; Yu HT; Kim TH; Uhm JS; Kim JY; Pak HN; Lee MH; Joung B; Lip GYH
Mayo Clin Proc; 2019 Feb; 94(2):225-235. PubMed ID: 30711120
[TBL] [Abstract][Full Text] [Related]
11. Atrial fibrillation risk in metabolically healthy obesity: A nationwide population-based study.
Lee H; Choi EK; Lee SH; Han KD; Rhee TM; Park CS; Lee SR; Choe WS; Lim WH; Kang SH; Cha MJ; Oh S
Int J Cardiol; 2017 Aug; 240():221-227. PubMed ID: 28385358
[TBL] [Abstract][Full Text] [Related]
12. C-reactive protein and risk of atrial fibrillation in East Asians.
Kwon CH; Kang JG; Lee HJ; Kim NH; Sung JW; Cheong E; Sung KC
Europace; 2017 Oct; 19(10):1643-1649. PubMed ID: 27915263
[TBL] [Abstract][Full Text] [Related]
13. Central obesity is important but not essential component of the metabolic syndrome for predicting diabetes mellitus in a hypertensive family-based cohort. Results from the Stanford Asia-pacific program for hypertension and insulin resistance (SAPPHIRe) Taiwan follow-up study.
Lee IT; Chiu YF; Hwu CM; He CT; Chiang FT; Lin YC; Assimes T; Curb JD; Sheu WH
Cardiovasc Diabetol; 2012 Apr; 11():43. PubMed ID: 22537054
[TBL] [Abstract][Full Text] [Related]
14. Obesity and the risk of new-onset atrial fibrillation.
Wang TJ; Parise H; Levy D; D'Agostino RB; Wolf PA; Vasan RS; Benjamin EJ
JAMA; 2004 Nov; 292(20):2471-7. PubMed ID: 15562125
[TBL] [Abstract][Full Text] [Related]
15. Atrial fibrillation in the cardiometabolic patient.
De Sensi F; Costantino S; Limbruno U; Paneni F
Minerva Med; 2019 Apr; 110(2):157-167. PubMed ID: 30371045
[TBL] [Abstract][Full Text] [Related]
16. The relationship between decreased pulmonary function and atrial fibrillation in general population: Findings from Ansung-Ansan cohort of the Korean Genome and Epidemiology Study.
Kim BS; Park JK; Lee Y; Shin JH; Lim YH; Park HC; Kim CK; Shin J
J Cardiol; 2019 Dec; 74(6):488-493. PubMed ID: 31253525
[TBL] [Abstract][Full Text] [Related]
17. Association of obesity with incident atrial fibrillation in Korea and the United Kingdom.
Choi SH; Yang PS; Kim D; Sung JH; Jang E; Yu HT; Kim TH; Pak HN; Lee MH; Lip GYH; Joung B
Sci Rep; 2023 Mar; 13(1):5197. PubMed ID: 36997588
[TBL] [Abstract][Full Text] [Related]
18. Non-alcoholic fatty liver disease (NAFLD), metabolic syndrome and cardiovascular events in atrial fibrillation. A prospective multicenter cohort study.
Pastori D; Sciacqua A; Marcucci R; Del Ben M; Baratta F; Violi F; Pignatelli P;
Intern Emerg Med; 2021 Nov; 16(8):2063-2068. PubMed ID: 33713286
[TBL] [Abstract][Full Text] [Related]
19. Association of metabolic syndrome with non-thromboembolic adverse cardiac outcomes in patients with atrial fibrillation.
Polovina M; Hindricks G; Maggioni A; Piepoli M; Vardas P; Ašanin M; Ðikic D; Ðuricic N; Milinkovic I; Seferovic PM
Eur Heart J; 2018 Dec; 39(45):4030-4039. PubMed ID: 30101326
[TBL] [Abstract][Full Text] [Related]
20. Metabolic syndrome and risk of Parkinson disease: A nationwide cohort study.
Nam GE; Kim SM; Han K; Kim NH; Chung HS; Kim JW; Han B; Cho SJ; Yu JH; Park YG; Choi KM
PLoS Med; 2018 Aug; 15(8):e1002640. PubMed ID: 30130376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
